Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 78
Filter
1.
Eur Radiol ; 25(5): 1247-56, 2015 May.
Article in English | MEDLINE | ID: mdl-25749786

ABSTRACT

OBJECTIVES: The objectives are determine the optimal combination of MR parameters for discriminating tumour within the prostate using linear discriminant analysis (LDA) and to compare model accuracy with that of an experienced radiologist. METHODS: Multiparameter MRIs in 24 patients before prostatectomy were acquired. Tumour outlines from whole-mount histology, T2-defined peripheral zone (PZ), and central gland (CG) were superimposed onto slice-matched parametric maps. T2, Apparent Diffusion Coefficient, initial area under the gadolinium curve, vascular parameters (K(trans),Kep,Ve), and (choline+polyamines+creatine)/citrate were compared between tumour and non-tumour tissues. Receiver operating characteristic (ROC) curves determined sensitivity and specificity at spectroscopic voxel resolution and per lesion, and LDA determined the optimal multiparametric model for identifying tumours. Accuracy was compared with an expert observer. RESULTS: Tumours were significantly different from PZ and CG for all parameters (all p < 0.001). Area under the ROC curve for discriminating tumour from non-tumour was significantly greater (p < 0.001) for the multiparametric model than for individual parameters; at 90 % specificity, sensitivity was 41 % (MRSI voxel resolution) and 59 % per lesion. At this specificity, an expert observer achieved 28 % and 49 % sensitivity, respectively. CONCLUSION: The model was more accurate when parameters from all techniques were included and performed better than an expert observer evaluating these data. KEY POINTS: • The combined model increases diagnostic accuracy in prostate cancer compared with individual parameters • The optimal combined model includes parameters from diffusion, spectroscopy, perfusion, and anatominal MRI • The computed model improves tumour detection compared to an expert viewing parametric maps.


Subject(s)
Contrast Media , Magnetic Resonance Imaging/methods , Magnetic Resonance Spectroscopy/methods , Prostatic Neoplasms/pathology , Aged , Diffusion Magnetic Resonance Imaging/methods , Humans , Image Enhancement/methods , Male , Middle Aged , Prospective Studies , Prostate/pathology , ROC Curve , Sensitivity and Specificity
2.
Prostate Cancer Prostatic Dis ; 14(1): 46-52, 2011 Mar.
Article in English | MEDLINE | ID: mdl-20498680

ABSTRACT

It has been suggested that in multifocal prostate cancer (PCa), focal therapy to the largest (index) lesion is sufficient, because secondary non-index lesions are unlikely to contribute to disease progression. In this study, the role of PCa focality in selecting men for focal therapy was evaluated. A histopathological analysis of the index and non-index lesions of 100 consecutive radical prostatectomy specimens was carried out. Cases that would have been suitable for focal ablation were also evaluated. Tumours were more often multifocal (78%) and bilateral (86%). In total, 270 tumour foci were identified. In multifocal disease, tumour volume, Gleason score and pathological stage were almost invariably defined by the index lesion of the specimen; among the 170 satellite foci, 148 (87%) were <0.5 cm(3) and 169 (99.4%) had Gleason score ≤ 6. Using the defined criteria, 51% of men in this series would have been considered suitable for focal ablation of the index lesion. Histological features of poor prognosis in the prostate are associated with the index lesion. There is a high proportion of patients who may be suitable for focal therapy, and clinical trials of index lesion ablation should be considered as part of this therapeutic strategy.


Subject(s)
Patient Selection , Prostatic Neoplasms/pathology , Prostatic Neoplasms/therapy , Aged , Cohort Studies , Humans , Male , Middle Aged , Neoplasm Staging , Prognosis , Prostatectomy , Prostatic Neoplasms/surgery , United Kingdom
3.
Breast ; 14(1): 42-50, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15695080

ABSTRACT

Local recurrence in breast cancer surgery is related to the completeness of excision. Histological analysis of excision margins is time consuming and impractical for use intra-operatively. Our group evaluated breast imprint and scrape cytology (ISC) for the assessment of excision margins in a feasibility study in 1993-4, with 10 year clinical follow-up. Twenty-six consecutive women undergoing 27 wide local excisions for breast cancer had excision margins prospectively assessed with intra-operative ISC blinded to histology. All ISC results were ready (range 22-30 min) before surgery was completed. ISC agreed with histology in 21/27 (=78%) and disagreed in 6/27 (=22%) of the cases. In two cases with local recurrence, histology was positive in one case, whereas ISC margins were positive in both. Intra-operative ISC is reliable and could help the surgeon to excise more tissue to prevent a second (re-excision) operation. ISC margins may predict clinical outcome, although a larger interventional follow-up study is required.


Subject(s)
Breast Neoplasms/pathology , Breast Neoplasms/surgery , Mastectomy, Segmental/methods , Neoplasm Recurrence, Local/surgery , Adult , Aged , Aged, 80 and over , Cytological Techniques , Female , Humans , Intraoperative Period , Middle Aged , Observer Variation , Prospective Studies
4.
Br J Cancer ; 88(7): 1071-6, 2003 Apr 07.
Article in English | MEDLINE | ID: mdl-12671707

ABSTRACT

Currently, the therapy for breast cancer is determined by immunohistochemical staining of the primary tumour for oestrogen receptor alpha (ERalpha). However, a proportion of ERalpha-positive patients fail to respond to tamoxifen and a proportion of ERalpha-negative patients show response. Here, we describe a novel procedure for the purification of malignant breast epithelial cells in an attempt to identify these patients at an early stage. Using this procedure, we are able to purify malignant cells to >90% purity as determined by immunohistochemical staining, cytology and fluorescent in situ hybridisation (FISH). While the malignant cells can be maintained in culture they do not proliferate in contrast to purified breast epithelial cells from reduction mammoplasties. Moreover, ERalpha and progesterone receptor (PR) expression is maintained in malignant cells, whereas normal epithelial cells rapidly lose ERalpha and PR. Functional studies were performed on the separated malignant cells in terms of their response to oestradiol and tamoxifen. Four out of the seven ERalpha-positive tumours showed a significant reduction in cell numbers after tamoxifen treatment compared to oestradiol, ERalpha negative tumours failed to show a response. We conclude that (a) it is possible to purify and maintain breast cancer cells for a sufficient period to permit functional studies and (b) ERalpha is retained in culture facilitating the use of these cells in studies of the mechanism of endocrine response and resistance in vitro.


Subject(s)
Breast Neoplasms/pathology , Breast/drug effects , Estradiol/pharmacology , Breast/cytology , Cell Separation , Cell Survival/drug effects , Epithelial Cells/drug effects , Female , Humans , Mammography , Tamoxifen/pharmacology , Tumor Cells, Cultured
5.
Ophthalmology ; 108(5): 985-8, 2001 May.
Article in English | MEDLINE | ID: mdl-11320032

ABSTRACT

PURPOSE: To assess p53 expression and proliferative activity in primary and recurrent pterygia from the same eyes. DESIGN: Retrospective comparative human tissue study. PARTICIPANTS: Tissue from excised primary pterygia that did not recur (group A, n = 10) was compared with tissue from primary pterygia that recurred (group B, n = 10) and to the recurrent pterygia tissue that was excised from subjects in group B (group C, n = 10). Ten normal conjunctivas served as controls (group D). METHODS: Sections from each pterygium were immunostained with the MIB-1 and bp53. 12 monoclonal antibodies that react with Ki-67 and p53 antigens, respectively. MAIN OUTCOME MEASURES: Proliferative activity was calculated as the mean of the MIB-1 positive cell count per eyepiece grid in high magnification (x40) (positive cell count/grid). Percentage of positive cells of all cells in the grid area was evaluated in the p53-stained sections. RESULTS: Proliferative activity was found in the epithelium overlying the pterygia and normal conjunctiva. The mean MIB-1 positive cell count/grid +/- standard error was 2.84 +/- 1.07, 1.74 +/- 0.82, 3.83 +/- 1.35, and 0.86 +/- 0.33 in groups A, B, C, and D, respectively (P = 0.17, Kruskal-Wallis). P53 staining was found in 50% of pterygia in groups A, B, and C; none of the normal conjunctival tissues showed p53 immunoreactivity. Four of five p53-positive tissues in group B were p53-negative in group C. In the p53-positive pterygia, less than 10% of cells were p53 positive. However, p53-positive pterygia had higher mean MIB-1 positive cell count/grid +/- standard error as compared with the p53-negative lesions, 4.56 +/- 0.94 vs 1.39 +/- 0.59 (P = 0.021, Mann-Whitney). CONCLUSIONS: p53 immunoreactivity and high proliferative activity in the epithelium overlying the pterygium are not associated with recurrence of pterygium.


Subject(s)
Pterygium/metabolism , Tumor Suppressor Protein p53/metabolism , Antibodies, Monoclonal , Antigens, Nuclear , Biomarkers , Cell Division , Epithelium/metabolism , Epithelium/pathology , Humans , Immunoenzyme Techniques , Ki-67 Antigen/metabolism , Nuclear Proteins/metabolism , Pterygium/pathology , Recurrence , Retrospective Studies
6.
Ophthalmology ; 108(2): 367-71, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11158814

ABSTRACT

PURPOSE: To compare melanomas confined to the iris and those involving either the ciliary body or choroid for the histologic features of microcirculation patterns and tumor cell proliferation indices. DESIGN: Retrospective comparative human tissue study. PARTICIPANTS: Ninety-eight uveal melanomas were studied, including 18 tumors confined to the iris, 30 tumors involving the ciliary body, and 50 tumors confined to the choroid. METHODS: Formalin-fixed, paraffin-embedded sections from each tumor were stained with hematoxylin-eosin and with periodic acid-Schiff. Adjacent histologic sections were stained with the MIB-1 antibody that reacts with the Ki-67 antigen. MAIN OUTCOME MEASURES: Microcirculation patterns were assessed in the periodic acid-Schiff-stained sections. Proliferative activity was assessed in the MIB-1-stained sections. The mean MIB-1 positive cell count per high-power field (HPF) was calculated in 10 HPF (x 40) in the area of maximal immunoreactivity. Two observers evaluated each MIB-1-stained section, and the interobserver reproducibility was assessed. RESULTS: Histologic microcirculation patterns associated with death from metastatic disease in ciliary body and choroidal melanomas (parallel vessels with cross-linking and networks of back-to-back loops) were not found in any of the iris melanomas. By contrast, 34% and 63% of the choroidal and ciliary body melanomas, respectively, showed at least one of these patterns. The mean positive cell count per HPF +/- standard error was 19.9 +/- 3.5, 27 +/- 5.3, and 1.9 +/- 0.4 in choroidal, ciliary body, and iris melanoma, respectively (P: = 0.003, Kruskal-Wallis test). CONCLUSIONS: Melanoma confined to the iris is characterized by a low rate of proliferation and the histologic absence of microcirculation patterns associated with metastatic posterior uveal melanoma. Both features are consistent with the relatively benign nature of iris lesions compared with melanomas involving the ciliary body or choroid.


Subject(s)
Ki-67 Antigen/analysis , Melanoma/blood supply , Melanoma/chemistry , Nuclear Proteins/analysis , Uveal Neoplasms/blood supply , Uveal Neoplasms/chemistry , Adult , Aged , Antigens, Nuclear , Cell Division , Female , Humans , Immunoenzyme Techniques , Male , Melanoma/pathology , Microcirculation , Middle Aged , Observer Variation , Periodic Acid-Schiff Reaction , Reproducibility of Results , Retrospective Studies , Uveal Neoplasms/pathology
7.
Hum Mol Genet ; 9(9): 1273-81, 2000 May 22.
Article in English | MEDLINE | ID: mdl-10814709

ABSTRACT

Hypersensitivity to acetylcholinesterase inhibitors (anti-AChEs) causes severe nervous system symptoms under low dose exposure. In search of direct genetic origin(s) for this sensitivity, we studied six regions in the extended 22 kb promoter of the ACHE gene in individuals who presented adverse responses to anti-AChEs and in randomly chosen controls. Two contiguous mutations, a T-->A substitution, disrupting a putative glucocorticoid response element, and a 4-bp deletion, abolishing one of two adjacent HNF3 binding sites, were identified 17 kb upstream of the transcription start site. Allele frequencies for these mutations were 0.006 and 0.012, respectively, in 333 individuals of various ethnic origins, with a strong linkage between the deletion and the biochemically neutral H322N mutation in the coding region of ACHE. Heterozygous carriers of the deletion included a proband who presented with acute hypersensitivity to the anti-AChE pyridostigmine and another with unexplained excessive vomiting during a fourth pregnancy following three spontaneous abortions. Electromobility shift assays, transfection studies and measurements of AChE levels in immortalized lymphocytes as well as in peripheral blood from both carriers and non-carriers, revealed functional relevance for this mutation both in vitro and in vivo and showed it to increase AChE expression, probably by alleviating competition between the two hepatocyte nuclear factor 3 binding sites. Moreover, AChE-overexpressing transgenic mice, unlike normal FVB/N mice, displayed anti-AChE hypersensitivity and failed to transcriptionally induce AChE production following exposure to anti-AChEs. Our findings point to promoter polymorphism(s) in the ACHE gene as the dominant susceptibility factor(s) for adverse responses to exposure or to treatment with anti-AChEs.


Subject(s)
Acetylcholinesterase/genetics , Polymorphism, Genetic , Promoter Regions, Genetic , Transcription Factors , Acetylcholinesterase/blood , Acetylcholinesterase/metabolism , Adult , Aged , Alleles , Animals , Base Sequence , Binding Sites/genetics , Brain/metabolism , DNA Mutational Analysis , DNA-Binding Proteins/metabolism , Enzyme Activation , Female , Gene Deletion , Gene Frequency , Genetic Predisposition to Disease , Genotype , Hematopoietic Stem Cells/metabolism , Hepatocyte Nuclear Factor 3-beta , Heterozygote , Humans , Hypersensitivity/genetics , Male , Mice , Mice, Transgenic , Molecular Sequence Data , Nuclear Proteins/metabolism , Point Mutation , Protein Binding , Pyridostigmine Bromide/immunology , Transcription, Genetic
8.
Ophthalmic Res ; 31(3): 210-2, 1999.
Article in English | MEDLINE | ID: mdl-10224504

ABSTRACT

Conjunctival primary acquired melanosis (PAM) is a frequent precursor of conjunctival melanoma. Since there is indirect evidence that the conjunctiva is an estrogen-responsive tissue, and since it was suspected that estrogen has a role in the etiology of melanoma, we decided to evaluate whether PAM may be responsive to estrogen. Formalin-fixed, paraffin-embedded sections from 13 cases of PAM and 2 cases of conjunctival melanoma were immunostained with an estrogen-receptor (ER)-specific antibody. All lesions and the normal conjunctival tissue adjacent to the lesions were found to be ER negative. It is concluded that PAM and normal conjunctiva are not sensitive directly to estrogen. When considering previously reported data, it is conceivable that the normal conjunctiva, but not PAM, is indirectly affected by estrogen.


Subject(s)
Conjunctiva/metabolism , Melanosis/metabolism , Receptors, Estrogen/metabolism , Adolescent , Adult , Aged , Antibodies, Monoclonal , Conjunctival Neoplasms/metabolism , Female , Humans , Immunohistochemistry/methods , Male , Melanoma/metabolism , Middle Aged , Staining and Labeling
9.
Am J Kidney Dis ; 32(5): 825-8, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9820454

ABSTRACT

Systemic lupus erythematosus (SLE) is a multisystem disease of unknown origin, characterized by a variety of autoimmune phenomena. Viruses have long been postulated to play a role in its pathogenesis. Several observations suggested a link between Epstein-Barr virus (EBV) and SLE. We describe a 14-year-old girl who presented with acute onset of SLE concurrently with clinical and laboratory findings consistent with EBV-induced infectious mononucleosis (IM). Evidence for acute EBV infection was confirmed by serological studies and detection of specific EBV antigens on kidney biopsy. This close association between EBV and SLE suggests a possible role of the virus in the pathogenesis of SLE in this patient.


Subject(s)
Epstein-Barr Virus Infections/diagnosis , Lupus Erythematosus, Systemic/virology , Acute Disease , Adolescent , Antigens, Viral/analysis , Autoimmune Diseases/virology , Biopsy , Female , Glomerulonephritis/immunology , Glomerulonephritis/virology , Herpesvirus 4, Human/immunology , Humans , Infectious Mononucleosis/diagnosis , Kidney/immunology , Kidney/virology
10.
Br J Ophthalmol ; 82(11): 1316-9, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9924341

ABSTRACT

AIMS: To compare the proliferative activity of intraepithelial melanocytes in primary acquired melanosis (PAM) without atypia and PAM with atypia by immunohistochemical staining for the Ki-67 antigen and the proliferating cell nuclear antigen (PCNA). METHODS: Formalin fixed, paraffin embedded sections from 35 archival specimens of PAM without atypia (n = 19) and with atypia (n = 16) were studied by immunostaining with MIB-1 and PC-10 monoclonal antibodies that react with the Ki-67 antigen and PCNA respectively. The results were calculated as the mean number of positive cells per eyepiece grid. All specimens were evaluated by two masked observers, and the interobserver reproducibility was assessed. RESULTS: The means of the positive cell count in PAM with atypia were significantly higher compared with PAM without atypia for both observers, in both the PC-10 and the MIB-1 stained sections. In a linear least square model that estimated the interobserver and between group variation, the difference of MIB-1 and PC-10 positive cell count between PAM without and with atypia remained highly significant. The difference between the observers was not significant. CONCLUSIONS: Immunostaining with MIB-1 and PC-10 demonstrated that PAM with atypia has higher proliferative activity than PAM without atypia. This method was found to be reproducible between different observers.


Subject(s)
Ki-67 Antigen/metabolism , Melanosis/metabolism , Nuclear Proteins/metabolism , Proliferating Cell Nuclear Antigen/metabolism , Antigens, Nuclear , Biomarkers , Cell Division , Humans , Immunohistochemistry , Melanosis/pathology
11.
Toxicol Lett ; 102-103: 205-9, 1998 Dec 28.
Article in English | MEDLINE | ID: mdl-10022255

ABSTRACT

Natural and man-made anticholinesterases comprise a significant share of the Xenobiotic poisons to which many living organisms are exposed. To evaluate the potential correlation between the resistance of acetylcholinesterase (AChE) to such toxic agents and the systemic toxicity they confer, we characterized the sensitivity of AChE from Xenopus laevis tadpoles to inhibitors, examined the susceptibility of such tadpoles to poisoning by various anticholinesterases and tested the inhibitor sensitivities of recombinant human AChE produced in these amphibian embryos from microinjected DNA. Our findings reveal exceptionally high resistance of Xenopus AChE to carbamate, organophosphate and quaternary anticholinesterases. In spite of the effective in vivo penetrance to Xenopus tadpole tissues of paraoxon, the poisonous metabolite of the pro-insecticide parathion, the amphibian embryos displayed impressive resistance to this organophosphorous agent. The species specificity of this phenomenon was clearly displayed in Xenopus tadpoles expressing recombinant human AChE, which was far more sensitive than the frog enzyme to in vivo paraoxon inhibition. Our findings demonstrate a clear correlation between AChE susceptibility to enzymatic inhibition and the systemic toxicity of anticholinesterases and raise a serious concern regarding the use of Xenopus tadpoles for developmental toxicology tests of anticholinesterases.


Subject(s)
Cholinesterase Inhibitors/toxicity , Xenopus laevis/metabolism , Animals , Drug Resistance , Humans , Paraoxon/toxicity , Species Specificity , Xenopus laevis/embryology
13.
Gynecol Oncol ; 64(3): 516-20, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9062163

ABSTRACT

The development of colon carcinoma during pregnancy is a rare event. However, when colon carcinoma develops during pregnancy it is considered a lethal coincidence due to rapid progression. We report two rare cases of colon adenocarcinoma diagnosed during gestation. Both tumors displayed increased nuclear immunostaining for p53. The increased expression of p53 in tumor cells could indicate that the p53 gene is either mutated or stabilized or alternatively overexpressed as a responses to DNA damage. It is hypothesized that the development of colon carcinoma during pregnancy can be attributed to alterations of the p53 tumor suppressor gene or gene product on one hand and a maternal immune-tolerant state on the other.


Subject(s)
Adenocarcinoma/metabolism , Colonic Neoplasms/metabolism , Gene Expression Regulation, Neoplastic , Pregnancy Complications, Neoplastic/metabolism , Tumor Suppressor Protein p53/biosynthesis , Adenocarcinoma/genetics , Adult , Colonic Neoplasms/genetics , Female , Humans , Pregnancy
14.
Br J Surg ; 83(6): 816-9, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8696750

ABSTRACT

Fine-needle aspiration cytology (FNAC) of the breast was performed in 491 patients over a 3-year period. Some 365 examinations (74.3 percent) were performed by palpation and the remaining 126 (25.7 percent) by stereotaxis. Ninety-six patients were excluded because of inadequate follow-up. Using a standard method of reporting the results 247 smears were classified as C1 and C2, but based on clinical and radiological criteria excision biopsy was recommended and performed in 122 patients with these lesions. Twenty-two per cent of C2 lesions were found to be malignant after histological examination. Forty-two patients with C3 or C4 cytology were advised to have excision biopsy and 41 had surgery. In all but one case the lesion was found to be malignant histologically. Definitive surgery was performed on 106 patients with C5 cytology and the diagnosis of malignancy was confirmed histologically in 105 of them. FNAC is a useful diagnostic tool in breast screening but in view of the number of false-negative results, cytology alone is unreliable and, therefore, full triple assessment is recommended.


Subject(s)
Biopsy, Needle/methods , Breast Neoplasms/pathology , Adenocarcinoma/diagnostic imaging , Adenocarcinoma/pathology , Breast Neoplasms/diagnostic imaging , Carcinoma, Ductal, Breast/diagnostic imaging , Carcinoma, Ductal, Breast/pathology , Carcinoma, Lobular/diagnostic imaging , Carcinoma, Lobular/pathology , Female , Humans , Mammography , Palpation , Sensitivity and Specificity , Stereotaxic Techniques
15.
Liver Transpl Surg ; 2(3): 206-10, 1996 May.
Article in English | MEDLINE | ID: mdl-9346650

ABSTRACT

Hepatitis B virus (HBV) reinfection after liver transplantation is a major problem. HBV is mainly a hepatotrophic virus but replicates in many extrahepatic tissues. We present here two cases of infected patients who underwent liver transplantation. Both underwent bone marrow (BM) and liver biopsies after transplantation. Biopsy specimens were stained for hepatitis B surface antigen (HB-sAg), and bone marrow aspirates and were separated for all subsets of cells. In both cases, HBV DNA analysis detected DNA in all BM fractions after transplantation, but HBV recurrence was found only in one case. We suggest that graft reinfection after liver transplantation may be caused by active replication of HBV in extrahepatic tissues and that BM cells are probably one of the major sanctuaries. The use of immunoprophylaxis based on BM-HBV studies is discussed.


Subject(s)
Bone Marrow Cells/virology , Liver Transplantation/adverse effects , Hepatitis B/etiology , Hepatitis B virus , Humans , Recurrence
16.
Am J Physiol ; 270(1 Pt 1): E158-63, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8772488

ABSTRACT

Estrogen increases parathyroid hormone (PTH) mRNA levels in vivo in ovariectomized rats. We now show that the 19-norprogestin R-5020 given to weanling rats or mature ovariectomized rats led to a twofold increase in thyroparathyroid PTH mRNA levels. This increase in PTH mRNA occurred at 24 and 48 h after progesterone but not at 72 h. There were no changes in serum calcium. In vitro, in primary cultures of bovine parathyroid cells, progesterone increased PTH mRNA levels threefold at 10(-8) M and twofold at 10(-9) M after 24 h. Progesterone receptor (PR) mRNA was demonstrated in rat parathyroid tissue by in situ hybridization and in human parathyroid adenoma by immunohisto-chemistry. Changes in PTH mRNA levels during the rat estrous cycle were also studied. At proestrus and estrus PTH mRNA levels were increased significantly by three- and fourfold compared with diestrus. Our results confirm that the parathyroid gland is a target organ for the ovarian sex steroids estrogen and progesterone and are of physiological relevance as shown by the changes during estrus.


Subject(s)
Estrus/metabolism , Parathyroid Hormone/genetics , Progestins/pharmacology , RNA, Messenger/metabolism , Animals , Cattle , Cells, Cultured , Female , Gene Expression/drug effects , Ovariectomy , Parathyroid Glands/cytology , Parathyroid Glands/metabolism , Progesterone/pharmacology , Promegestone/pharmacology , Rats , Rats, Inbred Strains , Rats, Sprague-Dawley , Receptors, Progesterone/genetics , Receptors, Progesterone/metabolism , Weaning
17.
J Clin Invest ; 96(4): 1786-93, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7560070

ABSTRACT

Secondary hyperparathyroidism is characterized by an increase in parathyroid (PT) cell number, and parathyroid hormone (PTH) synthesis and secretion. It is still unknown as to what stimuli regulate PT cell proliferation and how they do this. We have studied rats with dietary-induced secondary hyper- and hypoparathyroidism, rats given 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and rats after 5/6 nephrectomy for the presence of PT cell proliferation and apoptosis. PT cell proliferation has been measured by staining for proliferating cell nuclear antigen (PCNA) and apoptosis by in situ detection of nuclear DNA fragmentation and correlated with serum biochemistry and PTH mRNA levels. A low calcium diet led to increased levels of PTH mRNA and a 10-fold increase in PT cell proliferation. A low phosphate diet led to decreased levels of PTH mRNA and the complete absence of PT cell proliferation. 1,25 (OH)2D3 (25 pmol/d x 3) led to a decrease in PTH mRNA levels and unlike the hypophosphatemic rats there was no decrease in cell proliferation. There were no cells undergoing apoptosis in any of the experimental conditions. The secondary hyperparathyroidism of 5/6 nephrectomized rats was characterized by an increase in PTH mRNA levels and PT cell proliferation which were both markedly decreased by a low phosphate diet. The number of PCNA positive cells was increased by a high phosphate diet. Therefore hypocalcemia, hyperphosphatemia and uremia lead to PT cell proliferation, and hypophosphatemia completely abolishes this effect. Injected 1,25 (OH)2D3 had no effect. These findings emphasize the importance of a normal phosphate and calcium in the prevention of PT cell hyperplasia.


Subject(s)
Calcium, Dietary/administration & dosage , Kidney Failure, Chronic/pathology , Parathyroid Glands/pathology , Phosphates/administration & dosage , Animals , Apoptosis , Calcitriol/pharmacology , Cell Division , Hyperplasia , Male , Parathyroid Glands/cytology , Parathyroid Hormone/genetics , Proliferating Cell Nuclear Antigen/analysis , RNA, Messenger/analysis , Rats
18.
Dig Dis Sci ; 40(9): 2010-5, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7555457

ABSTRACT

Fifteen consecutive patients with recently diagnosed colorectal cancer were studied for plasma and tumor tissue prolactin content. In eight patients (four men and four postmenopausal females), preoperative high plasmatic prolactin was found (mean 1553 nmol; range 516-3677 nmol). In three of them, prolactin was also present in the tumor cells. All plasma prolactin levels returned to normal after tumor resection and remained so during a three-month follow-up. The tumor stage by Duke distribution was similar for both high and normal plasmatic prolactin patients. The role of prolactin in the pathogenesis of colorectal cancer, and as a marker of the tumor, remains to be established. This is the first time that prolactin has been detected in human colon cancer.


Subject(s)
Colonic Neoplasms/chemistry , Prolactin/analysis , Aged , Biomarkers, Tumor/analysis , Biomarkers, Tumor/blood , Colon/pathology , Colonic Neoplasms/blood , Colonic Neoplasms/pathology , Colonic Neoplasms/surgery , Female , Follow-Up Studies , Humans , Immunoenzyme Techniques , Male , Neoplasm Staging , Postmenopause , Prolactin/blood , Time Factors
20.
Cancer ; 75(10): 2420-6, 1995 May 15.
Article in English | MEDLINE | ID: mdl-7736384

ABSTRACT

BACKGROUND: Mutated p53 acts as a dominant oncogene, whereas the wild type (wt) p53 gene product suppresses cell growth. Abnormalities in the p53 gene are reported in more than 50% of malignant tumors. Recently, an allelic loss of chromosome 17p, where the p53 gene is located, was found to be more frequent in hepatocellular carcinoma (HCC) cell lines and human tumors. In addition, in half of the cases of HCC from endemic areas for hepatitis B virus and aflatoxin, a hot spot point mutation at codon 249 was detected, as previously reported. Missense mutations in p53, mdm-2 complex formation, and other unknown mechanisms may lead to stabilization of the gene product, thus rendering it detectable by immunohistochemistry. METHODS: To assess the relationship between p53 status at a premalignant stage and in HCC, the authors studied the immunohistologic expression of p53 in HCC and in the adjacent nontumorous resected liver tissue, using monoclonal antibody to wt and mutated p53. RESULTS: Twelve of the 14 patients with liver tumors had HCC. Of the 12 patients with HCC and underlying cirrhosis, 8 (67%) had increased p53 expression in HCC cells. Eight of the 12 patients with p53-positive HCC cells had p53 overexpression in the nontumorous hepatocytes within regenerative nodules adjacent to HCC tissue. Three of 21 cirrhotic livers without a detectable tumor had increased p53 expression in the regenerative nodules. None of the 12 patients with chronic active hepatitis without cirrhosis or the 13 with a normal liver histology had increased p53 expression. CONCLUSION: p53 overexpression in some cirrhotic livers and in nontumorous livers of patients with HCC may indicate a normal p53 gene response to cellular stress or, alternatively, to an abnormally or mutated p53 gene, and could occur before the development of HCC.


Subject(s)
Carcinoma, Hepatocellular/complications , Carcinoma, Hepatocellular/genetics , Gene Expression Regulation, Neoplastic , Gene Expression Regulation , Genes, p53/genetics , Liver Cirrhosis/complications , Liver Cirrhosis/genetics , Liver Neoplasms/complications , Liver Neoplasms/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Hepatitis, Chronic/complications , Hepatitis, Chronic/genetics , Humans , Liver/metabolism , Liver Regeneration/genetics , Male , Middle Aged , Mutation/genetics , Precancerous Conditions/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...